相关实验视频

Updated: Jun 25, 2025

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

对结直肠癌中的POLE/POLD1基因组变异进行了全面分析

Osama Mosalem¹, Tucker W Coston², Robin Imperial¹

¹Department of Medicine, Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.

|May 22, 2024

概括

结直肠癌中POLE/POLD1基因的突变与高瘤突变负担 (TMB-H) 有关. 识别POLE/POLD1短变异突变对于潜在的免疫治疗异常反应至关重要.

科学领域:

基因组学就是基因组学.
在瘤学瘤学.
分子生物学分子生物学

背景情况:

在POLE/POLD1中的致病突变会损害DNA复制效率,导致高瘤突变负担 (TMB-H).
这种TMB-H表型是独立于缺陷不匹配修复 (dMMR) 和微卫星不稳定性高 (MSI-H) 状态观察到的.

研究的目的:

调查结直肠癌中POLE/POLD1变化的频率和特征.
分析POLE/POLD1突变与瘤突变负担 (TMB) 之间的关联,并确定同时发生的分子变化.

主要方法:

分析了使用Tempus xT测定 (DNA测序) 分析的9136名CRC患者的非识别记录.
评估POLE/POLD1基因组变异,包括副本数变异和短变异突变.
在POLE/POLD1突变和野生型 (WT) CRC样本之间对TMB和共同变异的分析进行比较.

主要成果:

在2.4%的CRC样本中发现了POLE/POLD1基因组变异,副本数丢失是最常见的类型.
患有POLE/POLD1突变的患者显示TMB-H的频率更高 (22%与WT中的9%相比,P<.001).
在POLE/POLD1中短变异突变与超高突变的表型 (中位数TMB159 mut/Mb) 和APC,ALK,ATM,BRCA2和RET等基因的共同突变增加有关.

结论:

POLE/POLD1突变显著影响免疫标记 (TMB,MMR,MSI-H) 和CRC中的分子共同变异.
一个具有POLE/POLD1短变异突变的独特子组 (所有CRC的0.4%) 呈现出超超突变的表型.
鉴定这种超突变子组是关键的,因为它们可能对免疫检查点抑制剂产生异常反应.

关键词:

修复DNA的修复DNA的修复结肠直肠癌是什么意思遗传学遗传学遗传学是一个基因组学就是基因组学.这些是瘤生物标志物.

更多相关视频

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...